Aquestive Therapeutics Inc (AQST)
3.28
+0.06
(+1.86%)
USD |
NASDAQ |
May 16, 16:00
3.13
-0.15
(-4.57%)
Pre-Market: 08:02
Aquestive Therapeutics Total Liabilities (Quarterly): 165.82M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 165.82M |
| December 31, 2023 | 163.90M |
| September 30, 2023 | 162.38M |
| June 30, 2023 | 163.64M |
| March 31, 2023 | 170.52M |
| December 31, 2022 | 175.62M |
| September 30, 2022 | 159.66M |
| June 30, 2022 | 152.67M |
| March 31, 2022 | 149.67M |
| December 31, 2021 | 144.13M |
| September 30, 2021 | 125.64M |
| June 30, 2021 | 120.64M |
| March 31, 2021 | 113.72M |
| Date | Value |
|---|---|
| December 31, 2020 | 111.38M |
| September 30, 2020 | 86.94M |
| June 30, 2020 | 84.93M |
| March 31, 2020 | 85.32M |
| December 31, 2019 | 84.60M |
| September 30, 2019 | 83.28M |
| June 30, 2019 | 75.06M |
| March 31, 2019 | 74.04M |
| December 31, 2018 | 76.77M |
| September 30, 2018 | 66.57M |
| June 30, 2018 | 78.79M |
| March 31, 2018 | 68.90M |
| December 31, 2017 | 69.61M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
75.06M
Minimum
Jun 2019
175.62M
Maximum
Dec 2022
128.98M
Average
134.88M
Median
Total Liabilities (Quarterly) Benchmarks
| Lifecore Biomedical Inc | 256.99M |
| Harrow Inc | 235.33M |
| Akebia Therapeutics Inc | 252.74M |
| 89bio Inc | 66.78M |
| Geron Corp | 137.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 129.52M |
| Shareholders Equity (Quarterly) | -36.30M |
| Debt to Equity Ratio | -0.7929 |
| Current Ratio | 6.279 |
| Net Debt Paydown Yield | 1.21% |